The chikungunya virus virus-like particle vaccine is well tolerated and shows high immunogenicity in both previous recipients ...

The chikungunya vaccination is recommended for those traveling to areas where there is a chikungunya outbreak.

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

The study conducted by IIT Roorkee is supported by the Indian Council of Medical Research (ICMR). It has been published in a ...

Taking proper precautions can significantly reduce the risk of infections, keep reading as we share some tips.

The health department has registered 10 chikungunya cases from March 4-10, prompting it to take preventive measures. The ...

Roorkee researchers have identified a new potential treatment for Chinkungunya, indicate that Efavirenz, a widely used HIV ...

Efavirenz (EFV), brand-named drugs such as Sustiva, is an antiretroviral drug utilized mostly for HIV/AIDS treatment and prevention. Efavirenz is a category of drugs that fall under non-nucleoside ...

Chikungunya is a mosquito-borne viral disease. The illness is marked by fever, severe joint pain, and muscle aches, and currently has no specific antiviral treatment. According to a the Centers ...

Valneva will provide a live webcast of its full-year 2024 results conference call beginning at 3 p.m. CET/10 a.m. EDT today. This webcast will also be available on the Company’s website. Please refer ...

The Oropouche virus has been linked to Zika-like outcomes in pregnant people, with cases more than doubling in 2024 ...